Ollin Biosciences

Ollin is developing a biologic treatment for retinal diseases that blocks two disease-causing pathways with one molecule.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2026
Ollin Hover Image